Ambuja Cements will conduct a non-deal roadshow for investors and analysts in Mumbai on June 16 and 17, 2026. The meetings will serve as a platform for interaction without the disclosure of any unpublished price sensitive information.

The event is scheduled to take place in a physical format, comprising both 1x1 and group meetings. The sessions are set to run from 11.00 am to 6.00 pm local time on both days.

Schedule of Interaction

The company stated that all discussions during the interaction will be based solely on publicly available information. This intimation was submitted pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Jefferies has maintained its Buy rating on Ambuja Cements , setting a target price of ₹595. The brokerage's stance is anchored in management's expressed confidence in delivering meaningful cost efficiencies, even as the company navigates a period of relative underperformance and a slower-than-anticipated recovery from its mergers and acquisitions activity.

Key Highlights from Jefferies' Assessment

The brokerage's continued positive outlook rests on several key factors related to Ambuja Cements' operational and strategic trajectory. The following table summarises the core details of Jefferies' rating:

Cost Savings as the Central Catalyst

At the heart of Jefferies' investment case is management's confidence in achieving ₹500 per tonne in cost savings over the next two years. The brokerage identifies visible and demonstrable progress on this cost reduction target as the primary lever for restoring investor confidence in Ambuja Cements. Cost improvement is positioned not merely as an operational goal but as a critical signal to the market that the company's strategic initiatives are yielding tangible results.

Underperformance and M&A Turnaround Challenges

Jefferies acknowledges that Ambuja Cements has faced recent underperformance, alongside a turnaround from its mergers and acquisitions activity that has progressed more slowly than initially expected. These factors have weighed on investor sentiment. However, the brokerage's maintained Buy rating reflects a view that the pathway to recovery remains intact, contingent on the delivery of the outlined cost efficiencies.

Outlook

With a target price of ₹595 and a Buy recommendation sustained, Jefferies signals that the risk-reward profile for Ambuja Cements remains favourable from its perspective. The brokerage underscores that tangible cost improvements will be the key metric for investors to monitor as the company works toward rebuilding confidence over the coming two years.